Tocilizumab therapy improves abnormal mitochondrial function in patients with systemic juvenile idiopathic arthritis (sJIA)

被引：0
|
作者：
Mima, Toru [1 ]
Aoki, Chieko [1 ]
Adachi, Yasuo [1 ]
Suguno, Hidehiko [1 ]
Lee, Hooiming [1 ]
Yoshio-Hoshino, Naoko [1 ]
Imagawa, Tomoyuki [2 ]
Mori, Masaaki [2 ]
Tomiita, Minako [2 ]
Iwata, Naomi [2 ]
Murata, Takuji [2 ]
Miyoshi, Mari [2 ]
Takei, Syuji [2 ]
Aihara, Yukoh [2 ]
Yokota, Shumpei [2 ]
Matsubara, Kenichi [3 ]
Nishimoto, Norihiro [1 ]
机构：
[1] Osaka Univ, Suita, Osaka, Japan
[2] Japanese MRA Study Grp JIA, Yokohama, Kanagawa, Japan
[3] DNA Chip Res Inc, Yokohama, Kanagawa, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S497 / S498
页数：2
相关论文
共 50 条
  • [1] Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. DATA from Russian Register of Sjia
    Alexeeva, Ekaterina
    Valieva, Saniya
    Denisova, Rina
    Bzarova, Tatyana
    Isayeva, Kseniya
    Sleptsova, Tatyana
    Mitenko, Elena
    Chistyakova, Evgeniya
    Fetisova, Anna
    Lomakina, Olga
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1002 - S1002
  • [2] PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF TOCILIZUMAB (TCZ) IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (sJIA).
    Zhang, X.
    Morcos, P. N.
    De Benedetti, F.
    Brunner, H.
    Ruperto, N.
    Schaefer, F.
    Roseti, S.
    Kenwright, A.
    Martini, A.
    Lovell, D.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S36 - S36
  • [3] Tocilizumab for Systemic Juvenile Idiopathic Arthritis
    Hagino, Noboru
    Yamaguchi, Ken-ichi
    Ohara, Yuri
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1256 - 1256
  • [4] Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data
    F De Benedetti
    H Brunner
    N Ruperto
    R Schneider
    P Woo
    R Burgos-Vargas
    P Dolezalova
    R Joos
    N Wulffraat
    Z Zuber
    F Zulian
    R Allen
    D Brown
    J Chaitow
    M Pardeo
    G Espada
    B Flato
    V Gerloni
    G Horneff
    S Wright
    A Kenwright
    D Lovell
    A Martini
    [J]. Pediatric Rheumatology, 9 (Suppl 1)
  • [5] Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data
    Fabrizio De Benedetti
    Hermine Brunner
    Nicola Ruperto
    R Cuttica
    Clara Malattia
    Rayfel Schneider
    Patricia Woo
    Despina Eleftheriou
    Eileen Baildam
    Ruben Burgos-Vargas
    Pavla Dolezalova
    Stella M Garay
    Rik Joos
    Nico Wulffraat
    Zbyszek Zuber
    Francesco Zulian
    Carine Wouters
    Ricardo M Xavier
    Lawrence Zemel
    Stephen Wright
    Andy Kenwright
    Alberto Martini
    Daniel Lovell
    [J]. Pediatric Rheumatology, 10 (Suppl 1)
  • [6] Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
    Herlin, Troels
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (06) : 517 - 525
  • [7] Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
    Murakami, Miho
    Tomiita, Minako
    Nishimoto, Norihiro
    [J]. OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2012, 4 : 71 - 79
  • [8] Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Kishimoto, Tadamitsu
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 735 - 743
  • [9] Systemic juvenile Arthritis (sJIA) A new Era for Therapy?
    Kerbl, R.
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2013, 161 (04) : 292 - 292
  • [10] ECONOMIC EVALUATION OF THE USE OF ANTI TNF'S AND TOCILIZUMAB FOR THE TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) IN MEXICO
    Lechuga, D.
    Alva, M.
    Carlos, F.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A38 - A38
12345